Month: August 2021

Categories
Pharmaceutical

Potential for Linac MR-RT Systems In Order to Enhance the Efficiency and Precision of Existing Cancer Treatments

According to Fact.MR market research survey, Sales of MRI-guided radiation therapy systems market is projected to record a cagr of approximately 20% through 2028. The MRI-guided radiation therapy systems industry has been underpinned by the emergence of advanced technologies in the healthcare and medical devices industries.

The relatively new technology for integrating magnetic resonance imaging (MRI) with radiation therapy is becoming increasingly prevalent, with revenues from the MRI-guided radiation therapy systems market exceeding US$ 220 Mn in 2018, according to a recent study by Fact.MR.  This remarkable growth potential of the MRI-guided radiation therapy systems market can be attributed to the burgeoning adoption of innovative technologies in cancer diagnosis & treatment, alongside the growing focus on patient-centric care.

Request a report sample to gain comprehensive market insights at

https://www.factmr.com/connectus/sample?flag=S&rep_id=2572

The study assesses macro and microeconomic factors that define the growth prospects of the MRI-guided radiation therapy systems market. It finds that leading players in the rapidly-growing healthcare sector are vying for new techniques in cancer treatment to compensate for involuntary patient movements and improve precision to a much higher degree. In addition, the paradigm shift in preference of cancer patients towards radiation therapies, from invasive to non-invasive procedures, is expected to remain instrumental in adoption of MRI-guided radiation therapy systems in cancer care.

“Leading cancer research institutes are exploring the potential for MRI in radiation therapy in order to enhance the efficiency and precision of existing cancer treatments. However, integrating MRI technology, which uses magnetic field to produce images, with an all-metal linear accelerator in radiation therapy devices requires exceptional technological expertise and a strong international consortium. Currently, Elekta and Viewray are the only two companies that have a strong foothold in the MRI-guided radiation therapy systems market, and it may be a while until new entrants make a foray into the market,” says Fact.MR.

Get Customization on this Research Report for specific research solutions:

https://www.factmr.com/connectus/sample?flag=RC&rep_id=2572

global mri guided radio therapy systems market snapshot

Hospitals Remain the Target Customers for Market Players

The study opines that hospital, with over 51% revenue share, will remain the target customer for players in the MRI-guided radiation therapy systems market in 2019. Opportunities abound for MRI-guided radiation therapy system developers,, with ongoing clinical development of high-tech procedures exploiting Linac MR-RT (Linear accelerators integrated with magnetic resonance radiotherapy).

The study also finds that radiotherapy centers are adopting technologically advanced MRI-compatible radiation models, to explore numerous possibilities to make radiotherapy treatment more effective. Market players are focusing on building a successful consortium with the help of physicians, clinicians, as well as Original Equipment Manufacturers (OEMs), to tap opportunities in the radiation therapy centers.

The study opines that the increasing healthcare expenditure in the United States (U.S.) will remain a key growth determinant of the MRI-guided radiation therapy systems market in North America. In 2017, the per capita health expenditure was over US$10,000 in the U.S., recording an increase of nearly 4% over 2016, according to studies. In addition, an alarming rise in the prevalence of cancer in the U.S. will reflect in a significant demand for MRI-guided radiation therapy systems in North America.

According to the study, North America accounted for 45% sales of MRI-guided radiation therapy systems in 2018. Healthcare organizations in the region are investing heavily in tech-driven radiation treatments for cancer. While demand remains robust in developed markets, developing economies are also emerging as attractive markets for MRI-guided radiation therapy systems. Increasing government investments in healthcare infrastructure in the region, are expected to create new opportunities for the players in the MRI-guided radiation therapy systems market.

Explore All Opportunities of MRI-guided radiation therapy systems Industry

https://www.factmr.com/checkout/2572

Market Segmentation

Global MRI-guided Radiation Therapy Systems   Market Analysis 2013-2017 and Forecast 2018-2028, by Product

Linac MR-RT Systems
Software

Global MRI-guided Radiation Therapy Systems   Market Analysis 2013-2017 and Forecast 2018-2028, by MR Dimensions

0.5 Tesla MR Scanner
1.5 Tesla MR Scanner

Global MRI-guided Radiation Therapy Systems   Market Analysis 2013-2017 and Forecast 2018-2028, by End User

Hospitals
Radiotherapy Centers
Cancer Research Institutes

Global MRI-guided Radiation Therapy Systems  Market Analysis 2013-2017 and Forecast 2018-2028, by Region

North America
Latin America
Europe
Asia Pacific
Middle East and Africa (MEA)

Top Key Players Involved in the MRI-guided Radiation Therapy Systems Industry

  • VIEWRAY TECHNOLOGIES, INC. 
  • Elekta AB

Explore Fact.MR’s Coverage on the Healthcare Domain

Wound Healing Supplement Market: A recent study by Fact.MR on the Wound Healing Supplement Market offers a 5-year forecast analysis for the period 2021 – 2031. The study analyzes key trends that are currently influencing the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Preparative Chromatography Market: Fact.MR’s extensive coverage of the Preparative Chromatography Market offers in-depth insights into the prominent growth dynamics that are likely to aid the expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Retail Genomics Market: The Retail Genomics Market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities, and trends expected to shape future expansion outlooks. The report provides a comprehensive assessment of the prominent segments and geographies which are likely to benefit market players in the forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Non-Aqueous Form Is Expected to be the Dominant Segment In the Sterile Active Pharmaceutical Ingredients Says Fact.MR Report

Rising acceptance of biologics and preventive medicines is expected to propel the demand for sterile active pharmaceutical ingredients. Significant accessibility to drugs, growing pharmaceutical spending, and rising demand for targeted therapy drugs are factors boosting sterile active pharmaceutical ingredients market growth. China and India are the prominent suppliers of sterile active pharmaceutical ingredients, globally. Manufacturers are focusing on the expansion of their manufacturing plants in these countries owing to low-cost production and cheap labor. On this premise, the overall sales of sterile active pharmaceutical ingredients was valued at US$53 Bn in 2018 and will witness dexterous growth through 2029.

 “Increasing investments for sterile fill-finish capabilities expansion and inclination towards in-house sterile API production as a cost reduction strategy by pharmaceutical manufacturers are anticipated to favor the global sterile active pharmaceutical ingredients market growth.” says the Fact.MR Analyst.

Request a report sample to gain comprehensive market insights at

https://www.factmr.com/connectus/sample?flag=S&rep_id=1702

Key Takeaways of Sterile Active Pharmaceutical Ingredients Market Study

  • By product type, monoclonal antibodies accounted for prominent market value share in the sterile active pharmaceutical ingredients market. This is primarily attributed to growing need for biologics and targeted therapies for treatment of chronic disorders such as cancer.
  • South Asia and East Asia collectively hold over 33% of the sterile active pharmaceutical ingredients market share owing to expansion of sterile active pharmaceutical ingredients manufacturing facilities for small API molecules in these regions.
  • Aqueous form is expected to be the dominant segment in the sterile active pharmaceutical ingredients market attributed to the ability to provide great solubility for non-water-soluble drugs.

Emphasis on Manufacturing Capability, Key Strategy Followed by Market Players

Sterile active pharmaceutical ingredients manufacturers are focusing on the expansion of manufacturing facilities and adopting advanced aseptic processing techniques. For instance, in October 2017, Corden Pharma GmbH announced a strategic investment of US$ 4 million in small molecule API development capacity in its Corden Pharma Switzerland facility. With growing investments for infrastructural and technological advancements, manufacturers are also focusing on the opening up of new production plants for sterile active pharmaceutical ingredients in emerging countries. For instance, in October 2018, Sun Pharmaceutical Industries Ltd. opened a new cGMP production line in Guwahati, India to enhance the manufacturing capacity of sterile products.

Get Customization on this Research Report for specific research solutions

https://www.factmr.com/connectus/sample?flag=RC&rep_id=1702

global sterile active pharmaceutical ingredients market

Key Segments of the Sterile Active Pharmaceutical Ingredients Market

Fact.MR’s study on the sterile active pharmaceutical ingredients market offers information divided into four important segments-product type, form and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product Type

  • Monoclonal Antibodies
  • Immunoglobulin
  • Cytokines
  • Insulin
  • Peptide Hormones
  • Blood Factors
  • Peptide Antibiotics
  • Vaccines
  • Small Molecule Antibiotics
  • Highly Potent Active Pharmaceutical Ingredients (HPAPI)
  • Others

Form

  • Aqueous
  • Non-Aqueous Liquid
  • Dry Powder

Explore All Opportunities of Sterile Active Pharmaceutical Ingredients Industry

https://www.factmr.com/checkout/1702

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Looking for more information?

The research study on the sterile active pharmaceutical ingredients market by Fact.MR incorporates an unbiased assessment of key demand-driving factors and trends, which have shaped the landscape of the sterile active pharmaceutical ingredients market over 2014 – 2018 and includes a detailed assessment of key parameters that are anticipated to exert influence during 2019 – 2029. Market statistics have been presented on the basis of product type (monoclonal antibodies, immunoglobulin, cytokines, insulin, peptide hormones, blood factors, peptide antibiotics, vaccines, small molecule antibiotics, highly potent active pharmaceutical ingredients (HPAPI), and others), and form (aqueous, non-aqueous liquid and dry powder) across seven major regions.

Explore Fact.MR’s Coverage on the Healthcare Domain

Wound Healing Supplement Market: A recent study by Fact.MR on the Wound Healing Supplement Market offers a 5-year forecast analysis for the period 2021 – 2031. The study analyzes key trends that are currently influencing the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Preparative Chromatography Market: Fact.MR’s extensive coverage of the Preparative Chromatography Market offers in-depth insights into the prominent growth dynamics that are likely to aid the expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Retail Genomics Market: The Retail Genomics Market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities, and trends expected to shape future expansion outlooks. The report provides a comprehensive assessment of the prominent segments and geographies which are likely to benefit market players in the forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Sale of Dual Chambered Prefilled Syringes in North America to Remain at the Forefront Finds Fact.MR

With increasing demand for efficient drug delivery systems, especially for injectable drug delivery, the need for innovative injectable drug delivery options has risen. Given the advantages of standalone drug injecting systems such as prefilled syringes, such as ease in use, and enhanced safety, their demand is expected to increase at a high pace in the coming years.

According to Fact.MR analysis on prefilled syringes, the global market for prefilled syringes is anticipated to expand at a meteoric rate during the period of forecast. The Sales of prefilled syringes are poised to grow at a volume CAGR of 9.1% during the period of assessment, 2017-2026, and the Revenue Share of prefilled syringes across the globe is estimated to cross US$ 11 Bn by end of the year of assessment (2026).

Manufacturers are focused on developing enhanced prefilled syringe systems to cater to the growing demand for these injectable drug delivery systems. For instance, Becton Dickinson has developed PosiFlush prefilled syringes with a 4% sodium citrate lock solution that can reduce the number of catheters for hemodialysis by about exchanged per 1000 days by about 59% thus minimizing risks.

Request a report sample to gain comprehensive market insights at

https://www.factmr.com/connectus/sample?flag=S&rep_id=603

The Market survey research report on global prefilled syringes market has profiled many such key companies involved in the manufacturing of prefilled syringes, such as

  • Unilife Corporation
  • Sterinova
  • SHL Group
  • NIPRO
  • Bespak
  • AptarGroup
  • West Pharmaceutical Services Inc.
  • Vetter Pharma International GmbH
  • Stevanato Group
  • SCHOTT AG

Get Customization on this Research Report for specific research solutions

https://www.factmr.com/connectus/sample?flag=RC&rep_id=603

Key Highlights on the Global Prefilled Syringes Market:

  • North America in terms of sale of prefilled syringes tops other regional market during the period of assessment. This regions, especially dominated by United States, has witnessed increased adoption of glass prefilled syringes owing to high presence of chronic disorders. On the other hand, Asia Pacific excluding Japan (APEJ) region is expected to showcase increased inclination towards these injectable drug delivery systems. Asia Pacific excluding Japan region has shown immense potential as a favorable market place for various end use industries owing to its huge business potential. This has increased the presence of various pharmaceutical industries in the region. Moreover, increasing population growth in China and India, along with aging population has raised the demand bar for prefilled syringes to inject drugs to treat diseases such as diabetes and other autoimmune disorders
  • By material type, glass based prefilled syringes hold the highest market share and sales of glass based prefilled syringes is estimated to surpass U$ 7.5 Bn by end of 2026. However, owing to high fragile nature of these syringes, manufacturers have developed polymer based prefilled syringes that are also gaining high traction. Polymer based prefilled syringes have a comparatively higher break resistance and do not react with the drug they carry

Full Access to the report is available at

https://www.factmr.com/checkout/603

  • With respect to distribution channels, hospitals are the most lucrative. Sale of both glass and polymer based prefilled syringes from hospitals is estimated to reach a value of over US$ 6.5 Bn by end of the year of assessment. Online pharmacies and specialty clinics are also expected to significantly contribute to the growth of the global prefilled syringes market in the coming years
  • By technology type, sale of conventional prefilled syringes is higher than safety prefilled syringes. However, rate of sales of safety prefilled syringes is expected grow at a higher pace than the conventional product during the period of forecast
  • By function type, single chambered prefilled syringes have gained high steam since past years. This segment is expected to grow at  higher rate during the period of forecast and the sale of single chambered prefilled syringes is estimated to reach a value of over US$ 8 Bn by end of the year of assessment (2026)

Explore Fact.MR’s Coverage on the Healthcare Domain

Wound Healing Supplement Market: A recent study by Fact.MR on the Wound Healing Supplement Market offers a 5-year forecast analysis for the period 2021 – 2031. The study analyzes key trends that are currently influencing the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Preparative Chromatography Market: Fact.MR’s extensive coverage of the Preparative Chromatography Market offers in-depth insights into the prominent growth dynamics that are likely to aid the expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Retail Genomics Market: The Retail Genomics Market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities, and trends expected to shape future expansion outlooks. The report provides a comprehensive assessment of the prominent segments and geographies which are likely to benefit market players in the forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Categories
Pharmaceutical

Vacutainer Market- North America accounts for approximately 50% of the global sales by the end of 2031

Rise in demand for serologic analysis and biopsy is evident due to high prevalence of numerous chronic diseases in the geriatric population. Changing demographics (ageing population) across developed regions is the requirement for medical equipment & devices at healthcare centres. Vacutainer manufacturers are concentrating on improving shelf life and production output to cater the growing market demand, globally. Increase in liquid biopsy analysis for non-invasive diagnostic applications and growing importance of pre-donation screening in blood transfusion are key enablers driving demand for vacutainers (vacuum-based blood collection tubes).

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=5719

At present, North America holds the largest (over 50%) revenue in the global vacutainer market, owing to well-established healthcare facilities in the region since decades, especially in United States. As per the report published by Fact.MR, the global vacutainer market is anticipated to exceed a valuation of US$ 2.4 Bn by 2021, and is expected to expand at an impressive CAGR of more than 7% over the forecast period of 2021 to 2031.

Key Takeaways from Market Study
  • In 2020, one-half of market revenue was generated solely by North America.
  • Vacutainers with additives account for more than 80% of global sales, and are utilised at large in North America.
  • In 2020, North America and Europe together accounted for three-fourth global market share. The European market is expected to offer more than US$ 440 Mn absolute dollar opportunity over the next ten years.
  • The market is highly concentrated in nature, with companies such as Becton, Dickinson & Company and Medtronic PLC holding around 33% of the global market share.
  • In terms of buyer, hospitals and clinics held around 38% of overall market share in 2020.
  • Application in venous blood collection amounts for over 65% overall demand.
  • The market in East Asia is projected to expand at a CAGR of around 11% throughout 2021-2031, while that in China at 14.5%.

vacutainer market region

“Large number of regional players in East Asia offering vacutainers at significantly lower cost makes it difficult for international players to expand in the region,” says a Fact.MR analyst.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=5719

Winning Strategy

Advancements in technology related to medication and new ways of drawing blood for biopsy are likely to impact the current medical equipment market in the near future. Devices such as Velano Vascular’s PIVO, which provided a new approach to draw blood and made it easier to avoid acute pain through its needle-less blood drawing system, are the future of blood drawing systems. Owing to the needs of end users, innovation in vacutainers that allow an individual to collect blood (with less penetration of needles) without the support of doctors or clinical staff can be a key winning strategy for manufacturers.

More Valuable Insights

Fact.MR, in its new offering, presents an unbiased analysis of the global vacutainer market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study reveals essential insights on the basis of additive (with and without/no additive tubes), application (venous and capillary blood collection), buyer (research laboratories, hospitals & clinics, and diagnostic chains), and material (plastic (PET) and glass tubes), across seven regions of the world (North America, Latin America, Europe, MEA, East Asia, South Asia and Oceania).

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/vacutainer-market
Press Release: https://www.factmr.com/media-release/1896/global-vacutainer-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Veterinary Ophthalmic Equipment Market Booming Demand Leading To Exponential CAGR Growth By 2030 | Nanjing Redsun Optical Co., Ltd., Welch Allyn, HEINE Optotechnik GmbH & Co. KG, LKC Technologies, Inc

Demand for veterinary care has exponentially increased in recent times, due to which, demand for veterinaries and clinics has also increased. People spend more on veterinary services than on medicines. Since the advent of the Internet, knowledge sharing has helped people realize the importance of regular checkups for animals. Moreover, veterinary medical device manufacturers are emphasizing on collaborative manufacturing with regional manufacturing presence to grab a greater share in high potential untapped regions in the veterinary ophthalmic equipment market.

Moreover, growing veterinary healthcare spending and R&D investments, and increasing production of veterinary medical devices are some of the factors propelling the growth of the veterinary ophthalmic equipment market. For instance, in 2016, animal health manufacturers invested around US$ 46 Bn, whereas, non-IP-intensive industries invested around US$ 3.9 Bn in R&D. Workers in the animal health industry earned nearly 25% premium. The export per worker in the animal health industry is around two times that of the non-IP-intensive industry.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=5241

As per Fact.MR, the global veterinary ophthalmic equipment market is estimated to reach a valuation of US$ 785 Mn by the end of 2030.

Key Takeaways from Veterinary Ophthalmic Equipment Market Study
  • By product, diagnostic devices accounted for a prominent market value share in the veterinary ophthalmic equipment market, due to growing usage of these devices for various disease diagnosis applications.
  • North America and Europe collectively hold over 60% of the global veterinary ophthalmic equipment market share, owing to growing research and production activities in veterinary medical equipment manufacturing industries.
  • Based on end user, veterinary clinics accounted for more than half of the market value share in the global veterinary ophthalmic equipment market. However, the veterinary hospitals segment is expected to expand at a higher growth rate.
  • Demand for veterinary medical equipment in Europe and East Asia is also projected to surge at a significant rate during the forecast period.  Rising adoption of pets and increasing consumer spending on veterinary care are playing a crucial role in adoption of veterinary medical equipment in hospitals and clinics across the region.
  • The COVID-19 pandemic will have a short-term adverse effect on the expansion of the global veterinary ophthalmic equipment market.

veterinary ophthalmic equipment market product

“Rising adoption of pets and increasing consumer spending on veterinary care & funding are some of the factors anticipated to favor the growth of the global veterinary ophthalmic equipment market,” says a Fact.MR analyst.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=5241

Product Portfolio Expansion and Partnerships Key Strategies by Market Players

Icare Finland Oy, AMETEK, Inc. (Reichert, Inc.), HAAG-STREIT GROUP, and Nanjing Redsun Optical Co., Ltd. contributed a higher market value share in the global veterinary ophthalmic equipment market. Veterinary ophthalmic equipment manufacturers are focusing on expansion of product portfolios. For instance, in April 2019, Revenio Group acquired centerVeu to strengthen its position as a global market leader in devices for diagnostics and monitoring of eyes.

Manufacturers are also focusing on partnerships and agreements with other manufacturers to expand product sales. For instance, in April 2019, LKC Technologies announced Brazilian Health Regulatory Agency Approval for the RETeval® Device and Associated Sensor Strip Electrodes, which is another step in making functional diagnostics accessible to all clinicians, leading to faster diagnosis of complex eye diseases.

Get More Insights- https://www.prnewswire.com/news-releases/veterinary-ophthalmic-equipment-market-growth-banking-on-cataract–glaucoma-treatment-advances-for-animals-factmr-301244594.html

Looking for more information?

The research study on the veterinary ophthalmic equipment market by Fact.MR incorporates an unbiased assessment of key demand-driving factors and trends that have shaped the landscape of the veterinary ophthalmic equipment market over 2015 – 2019, and includes detailed assessment of key parameters that are anticipated to exert influence during 2020 – 2030. Market statistics have been presented on the basis of product type (diagnostic devices [tonometers, fundus cameras, portable ERG devices, ophthalmoscopes, and slit lamps] and surgical equipment [operating microscopes, phacoemulsification devices, opthalmic surgical instruments, bandage contact lenses, viscoelastics, and intraocular lenses]) and end user (veterinary medical centers and colleges, veterinary hospitals, and veterinary clinics), across seven major regions.

Explore Fact.MR’s Coverage on the Healthcare Domain

Veterinary Imaging Systems Market: A recent study by Fact.MR on the veterinary imaging systems market offers a 10-year forecast from 2017 to 2022. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Veterinary Respiratory Ventilators Market: Fact.MR’s recent report on the veterinary respiratory ventilators market offers a forecast from 2018 to 2028, highlighting such key aspects as drivers, opportunities and trends prevailing across the aforementioned period. The report provides a detailed analysis of key segments’ growth prospects across prominent geographies, along with information on the important stakeholders and manufacturers operating in the landscape.

Veterinary Radiography Flat Panel Detectors Market: A detailed assessment of global veterinary radiography flat panel detectors value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in Fact.MR’s elaborate coverage on the landscape. Statistics have been provided for key segments’ and their expansion prospects across prominent geographical locations.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/5241/veterinary-ophthalmic-equipment-market
Press Release: https://www.factmr.com/media-release/1705/global-veterinary-ophthalmic-equipment-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Multiphoton Microscopy Market- North America followed by Europe Account for the Largest Revenue Share of the Market during Forecast Period

Growing biomedical research for drug development and diagnostics of cancer is expected to build a favorable atmosphere for the growth of the multiphoton microscopy market in the near future. Moreover, various clinical development programs in several countries are focused at increasing cancer screening programs with the help of governments. This is leading to the early screening and diagnosis of cancer patients. Multiphoton microscopy is now also being used for imaging in clinical oncology diagnostic tests. Growing prevalence of cancer across the world is expected to fuel demand for multiphoton microscopy across geographies.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=3405

Currently, players in the multiphoton microscopy space are consistently making changes in their product categories and technologies in order to enhance device capabilities. For instance, in December 2020, ZEISS introduced ZEISS Lattice lightsheet 7; this product is tailored to observe cellular processes within cells and small organisms in 3D over extended time periods, all at a subcellular resolution with minimum light dosage.

The global multiphoton microscopy market was valued at around US$ 150 Mn in 2019, and is projected to expand at a CAGR of close to 5% through 2031.

multiphoton microscopy market region

Key Takeaways from Multiphoton Microscopy Market Study
  • Two-photon microscopy accounted for 94.2% market share in 2020.
  • Deep tissue imaging is the most lucrative segment and holds nearly 18% of the market share.
  • North America and Europe collectively hold over half of the global multiphoton microscopy market share, owing to technological advancements and increasing mergers and collaborations in these regions.
  • Hospitals & clinics account for over 5% value share, since they serve as the primary centers for disease diagnosis and treatment.
  • The COVID19 pandemic has resulted in a temporary pause of all non-essential and elective procedures. Medical device manufacturers have been severely impacted, with companies reporting significant drop in revenue due to the cancellation of diagnostic procedures.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=3405

“Rising adoption of e-Commerce and increasing technological advancements are factors anticipated to aid growth of the global multiphoton microscopy market over the coming years,” says a Fact.MR analyst.

Addition of Innovative Products in Portfolio through Partnerships

To retain their positions in the market, prominent medical device manufacturers are identifying potential assets from smaller firms, which typically have limited resources to see projects through to the market. Through licensing deals and partnerships, companies are acquiring new products, while continuing to pursue their own in-house development strategies.

  • For instance, in September, 2020, Bruker Corporation announced the acquisition of Canopy Biosciences, LLC, a leader in high multiplex biomarker imaging for immunology, immuno-oncology, and cell therapy. This acquisition enhances Bruker’s offerings in targeted multi-omics and fluorescence-based imaging techniques.

Get More Insights- https://www.biospace.com/article/multiphoton-microscopy-sales-set-to-grow-at-5-percent-by-2030-end-fact-mr/

Looking for more information?

The research study on the multiphoton microscopy market by Fact.MR incorporates an unbiased assessment of key demand-driving factors and trends, which have shaped the landscape over 2015 – 2019, and includes detailed assessment of key parameters that are anticipated to exert influence during 2020 – 2030. Market statistics have been presented based on product (two-photon microscopy and three-photon microscopy), application (skin imaging, neuroscience, oncology, immunology, embryology, deep tissue imaging, functional and molecular imaging, intravital imaging, cell culture, virology, and others), and end user (hospitals & clinics, clinical & diagnostic laboratories, and academic & research institutes), across seven regions – North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East & Africa.

Explore Fact.MR’s Coverage on the Healthcare Domain

Microcirculation Microscope Market: A recent study by Fact.MR on the Microcirculation Microscope market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the challenges, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Scanning Probe Microscopes Market: A detailed assessment of Scanning Probe Microscopes market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Microscopy Devices Market: Fact.MR delivers a detailed analysis on global Microscopy Devices market with the strategies and competitive landscape for the upcoming period. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/3405/multiphoton-microscopy-market
Press Release: https://www.factmr.com/media-release/1804/multiphoton-microscopy-market-trend
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Chromatography Syringes Market is estimated to reach approximately US$ 85 Million in revenues by 2022-end

The global chromatography syringes market is projected to exhibit an impressive expansion during the forecast period 2017 to 2022, according to a new study by Fact.MR. On the back of rising consumer concerns pertaining to food safety, coupled with continuous alterations in regulatory framework, demand for chromatography syringes is expected to witness a surge. Revenues from the global market for chromatography syringes will reach roughly US$ 85 Mn by 2022-end.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=153

Increasing Requirements in Research Activities to Fuel Market Growth of Chromatography Syringes

Chromatography tests have become indispensable for approval of drugs. A number of technological advancements have been observed in chromatography syringes, which aim to cater demand from various industries such as semiconductor, chemical, food & beverage, biopharmaceutical, and biotechnology. Over the past few years, the requirements for research activities have been soaring, which include robust adoption of chromatography in proteomics, purification of monoclonal antibodies, and green chromatography. These factors are likely to fuel growth of the global chromatography syringes market.

However, difficulty in utilization of chromatography syringes in conventional methods may act as a restraining factor for growth of the market. In addition, chromatography syringes have less sample capacity, which in turn makes chromatography a very time consuming process, and careful attention is required while using these syringes. This factor is further expected to hinder the market growth in the near future.

North America – Projected to Remain the Largest Market for Chromatography Syringes

In terms of revenues, North America is projected to remain the largest market for chromatography syringes, followed by Europe. However, sales of chromatography syringes in Asia-Pacific excluding Japan will continue to register a relatively higher CAGR than other regional segments through 2022.

Although gas chromatography will continue to be the most lucrative application of chromatography syringes, sales of chromatography syringes in high pressure liquid chromatography (HPLC) application are expected to exhibit the fastest expansion through 2022. Demand for chromatography syringes for application in thin layer chromatography is anticipated to remain relatively lower than other application segments over the forecast period.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=153

Autosampler syringes for chromatography are expected to remain sought-after among products in the market, accounting for over half market revenue share during 2017 to 2022. Sales of manual chromatography syringes will continue to exhibit a lower CAGR as compared to sales of autosampler syringes through 2022.

Sales of Chromatography Syringes in Pharmaceutical Industry to Exhibit Fastest Expansion through 2022

On the basis of end-users, research institutes are expected to remain dominant in the global market for chromatography syringes, however chromatography syringes sales in pharmaceutical industry will continue to reflect the fastest expansion through 2022.

Complete loop filling will continue to be most lucrative technology adopted in the global chromatography syringes market, with sales projected to surpass US$ 30 Mn in revenues by 2022-end. Demand for partial loop filling technology for chromatography syringes are anticipated to exhibit the highest CAGR through 2022.

Get More Insights- https://www.biospace.com/article/growing-requirement-of-research-activities-to-fuel-demand-for-chromatography-syringes-market-states-fact-mr/

Key market players mentioned in Fact.MR’s report include Trajan Scientific & Medical Pty Ltd., Hamilton Company, Valiant Co., Ltd., PerkinElmer, Inc., Agilent Technologies, Shimadzu Corporation, and Thermo Fisher Scientific, Inc.

Explore Fact.MR’s lucid coverage of the Healthcare landscape

Gas Chromatography Market : The global gas chromatography market is projected to exceed US$ 3,500 Million towards the end of 2022.

Ambient Temperature Gel Permeation Chromatography Market: Need for a particular high specialized high-temperature Gel permeation chromatography system amid their molecular weight distributions analysis restrains the market growth during 2018-2026.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/153/chromatography-syringes-market
Press Release: https://www.factmr.com/media-release/142/chromatography-syringes-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Normal Balloon Catheter Market- Europe to Account for the Largest Revenue Share of the Market during Forecast Period

Over the past few years, incidences of cardiovascular diseases have been witnessing a surge, coupled with the rising number of cardiology intervention procedures around the world. Governments are making provisions of reimbursement support for patients with vascular diseases.

Healthcare expenditure has also been experiencing a hike in the recent past. Factors such as these may impact the growth of the global normal balloon catheter market. In addition, numerous other factors including rising in the elder population, increasing investments in R&D activities associated with normal balloon catheters are further estimated to create growth opportunities for normal balloon catheter manufacturers.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=147

The global market for normal balloon catheters is set to exhibit an average CAGR throughout the forecast period (2017-2022). The global normal balloon catheter market will account for around US$ 2,000 Mn revenues by 2022-end.

However, factors such as high costs related to angioplasty procedures, along with risks concerning balloon catheterization including infection and artery collapse are anticipated to curb the growth of the global market for the normal balloon catheter.

Trends Being Observed in the Global Normal Balloon Catheter Market
  • Rise in interventional cardiology is facilitating the use of the normal balloon catheters
  • Surging prevalence of patients with end-stage renal disease have been fuelling demand for normal balloon catheters
  • The number of people undergoing renal replacement therapy is increasing, thereby fuelling the growth of the normal balloon catheter market

Normal balloon catheter sales in cardiac catheterization laboratories will register the fastest expansion over the forecast period, on the basis of end-users. In addition, hospitals are expected to retain their dominance in the global market for normal balloon catheters.

Market Taxonomy
Indication
  • Coronary Artery Disease
  • Peripheral Vascular Disease
End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories
Raw Material
  • Polyurethane
  • Nylon
  • Others
Hospitals to Remain the Largest End-Users of Normal Balloon Catheter

Sales of normal balloon catheter in cardiac catheterization laboratories are expected to exhibit the fastest expansion through 2022, based on end-users. Hospitals will remain the largest end-users of normal balloon catheter throughout the forecast period.

Nylon will continue to be the preferred raw material for manufacturing normal balloon catheter. Nearly half the revenue share of the market will be accounted for nylon, based on raw material. However, sales of polyurethane for the production of normal balloon catheter will register a comparatively higher CAGR than sales of nylon through 2022.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=147

Nylon to be Sought-after among Manufacturers of Normal Balloon Catheters

Based on raw material, nylon will remain sought-after among manufacturers of normal balloon catheters. Approximately half market share will be held by sales of nylon in the market during the forecast period. In addition, sales of polyurethane in the global market is expected to exhibit a relatively higher CAGR than that of nylon through 2022.

Coronary artery disease will continue to be dominant in the market, based on the indication. Sales of normal balloon catheters for coronary artery disease are anticipated to exceed revenues worth US$ 1,000 Mn by 2022-end. In terms of revenue, nearly three-fourth market share is estimated to be held by normal balloon catheter sales for coronary artery disease throughout the forecast period.

Get More Insights- https://www.accesswire.com/618349/Asthma-Treatment-Market-Growth-Bolstered-by-Sales-of-Long-Term-Asthma-Control-Medications-Opines-FactMR

Europe to Account for Largest Revenue Share of the Global Normal Balloon Catheter Market

Europe is projected to be the largest market for normal balloon catheter from 2017 to 2022, in terms of revenue. Sales of a normal balloon catheter in Europe will hold the largest revenue share of the market over the forecast period. In addition, normal balloon catheter sales in Asia-Pacific excluding Japan (APEJ) are expected to exhibit the fastest expansion through 2022. In contrast, the market in North America is anticipated to register the lowest CAGR through 2022.

Key market players profiled in the report include BIOTRONIK SE & Co. KG., Cordis Corporation, Cook Medical INC, Tokai Medical Products Inc., Hexacath, Meril Life Sciences Pvt. Ltd., B. Braun Melsungen AG, MicroPort Scientific Corporation, Terumo Corporation, Medtronic plc, Boston Scientific Corporation, and Abbott Laboratories.

Explore Wide-ranging Coverage of Fact.MR’s Healthcare Landscape

Asthma Spacers Market: Find insights on the Asthma Spacers market with analysis of segments, statistics, influencers, market players, and business strategies adopted over a 10-year forecast period.

Diverticular Disease Therapeutics Market: Fact.MR’s report on the diverticular disease therapeutics market offers insights on the market during 2018-2028, including restraints, revenue sources, market leaders, and market strategies.

Tumour-Induced Osteomalacia Market: Read an analysis of the tumour-induced osteomalacia market with insights on growth factors, opportunities, restraints, regional market forecast, regulatory policies, and strengths of market leaders.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/147/normal-balloon-catheter-market
Press Release: https://www.factmr.com/media-release/136/normal-balloon-catheter-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Asthma Treatment Market – North America is expected to have a large share, Says Fact.MR study

Retail pharmacies will drive the highest sales of asthma therapeutics with an estimated value of around US$ 17 Bn by 2027, as rapid expansion of retail pharmacies makes asthma therapeutics more accessible to patients. According to a recent Fact.MR study, hospital pharmacies with large drug inventories would also remain a crucial distribution channel in the asthma treatment market. As patients find it convenient to purchase drugs immediately after diagnosis, hospital pharmacies are likely to catalyze sales of asthma treatment during the forecast period (2020-2027). The study finds that, hospital pharmacies hold the potential to drive sales tantamount to US$ 10 Bn by 2027, in the asthma treatment market.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4422

North America to Hold Pole Position in Asthma Treatment Market; Asia Pacific Market to Gain Pace

North America would retain its pole position in the asthma treatment market, while the market in Asia Pacific is projected to witness the fastest growth rate. During the forecast period, North America would lose its market share to Asia Pacific, as leading players are gradually scrambling towards developing countries such as China and India to cash in on relatively cost-effective production opportunities. For instance, F.Hoffmann-La Roche Ltd. announced the inauguration of a new manufacturing facility for its pharmaceutical division in Shanghai, China.

Additionally, North America accounts for a high concentration of leading players; ones that generally develop branded drugs. On the contrary, players in the Asia Pacific asthma treatment market relatively hold a low market position, and are involved in the development of generic drugs. As a result, threat of patent expiration affects the North American market more adversely than Asia Pacific. On the back of shifting market trends towards Asia Pacific, the regional asthma treatment market is projected to gain significant pace during the forecast period.

assessing lucrativeness of asthma treatment market by treatment type

Key Highlights of Asthma Treatment Market Study
  • Sales of long-term asthma control medications would remain 59% higher as compared to quick-relief medications by 2027, as rescue medications have limited application scope (only used during asthma attacks), while long-term medications possess high efficacy to control asthma attacks.
  • Loss of patent exclusivity of branded drugs could affect the position of leading players in the asthma treatment market, as generic drugs gain ground. For instance, patents of Symbicort Turbuhaler and Qvar manufactured by AstraZeneca and GlaxoSmithKline PLC respectively, are to expire in the very near future. High availability of generic drugs to treat mild to severe asthma is projected to adversely affect revenue potential of the asthma treatment market during the forecast period.
  • Sales of inhalers are projected to cross US$ 14 Bn by 2027, and oral route of administration is likely to grow as the second-most attractive section in the asthma treatment market.
  • Relaxed FDI policies in India and China are projected to shift focus of leading players towards Asia Pacific to achieve reduced overhead costs and meet growing demand for asthma therapeutics in these countries. According to the Lung India Journal, India accounts for one in every 10 asthma patients. On the back of increasing demand for asthma therapeutics and improving supply chain, the Asia Pacific asthma treatment market is projected to witness growth in the market.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=4422

A senior research analyst at Fact.MR opines, “Growing acceptance of online shopping channels offering next-day/ same-day delivery features and attractive deals would increase sales through online pharmacies. The trend of ordering medications through online pharmacies would gain more prominence by 2027.”

High Reliance of Leading Players on Organic Growth Strategy

Leading players in the consolidated asthma treatment market, accounting for 60% of the total share, rely on organic growth strategy to develop an extensive product portfolios. These players aim to develop novel therapies and drugs through high investments in R&D activities. For instance, in 2018, AstraZeneca and its partner Amgen Inc., announced that the Food and Drug Administration (FDA) had granted Breakthrough Therapy designation to Tezepelumab, which is used for the treatment of severe asthma. Continuous introduction of new therapeutics strengthens their portfolios, and well-established brand identity of leading players further increases their sales prospects.

Get More Insights- https://www.accesswire.com/618349/Asthma-Treatment-Market-Growth-Bolstered-by-Sales-of-Long-Term-Asthma-Control-Medications-Opines-FactMR

Find More Valuable Insights on Asthma Treatment Market

Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global asthma treatment market, presenting historical demand data (2017-2019), and forecast statistics for the period of 2020-2027. The study divulges compelling insights on the asthma treatment market on the basis of treatment type (long-term asthma control medications and quick-relief (rescue) medications), route of administration (inhaled, oral, intravenous, and subcutaneous), and distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), across five major regions.

Explore Wide-ranging Coverage of Fact.MR’s Healthcare Landscape

Asthma Spacers Market: Find insights on the Asthma Spacers market with analysis of segments, statistics, influencers, market players, and business strategies adopted over a 10-year forecast period.

Diverticular Disease Therapeutics Market: Fact.MR’s report on the diverticular disease therapeutics market offers insights on the market during 2018-2028, including restraints, revenue sources, market leaders, and market strategies.

Tumour-Induced Osteomalacia Market: Read an analysis of the tumour-induced osteomalacia market with insights on growth factors, opportunities, restraints, regional market forecast, regulatory policies, and strengths of market leaders.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/4422/asthma-treatment-market
Press Release: https://www.factmr.com/media-release/1207/asthma-treatment-demand
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Intranasal migraine drugs Market to Witness a Tremendous Growth Due to COVID-19 Pandemic – Exclusive Report by Fact.MR

Award winning market research company Fact.MR’s ongoing research study on global intranasal migraine drugs market studies the market for the forecast period of 2021 and 2031. Rising cases of acute and chronic headache among the young-adult population is expected to increase the adoption of intranasal migraine drugs. Expansion in research and development activities for the development of novel treatments to provide quick relief for the cerebral and sinus pain will provide growth opportunities for the key players in the coming years.

According to Fact.MR, the market is expected to showcase a positive growth over the forecast period backed by the rising demand of intranasal migraine drugs from hospital & retail pharmacies. As per the analysis, around 95% of patients with migraine issues prefer the intranasal migraine drugs.

Request For A Brochure: https://www.factmr.com/connectus/sample?flag=S&rep_id=5612

There are some side-effects recorded such as quick heartbeat, muscle torment in legs/arms, and serious/moderate stomach torment that may hamper the demand. However, ongoing research & development (R&D) activities for the improvement of intranasal migraine drugs by manufacturers will overcome the constraints of the market. Hence, key players are investing heavily for the development of improved intranasal migraine drugs for the treatment of acute & chronic migraine. Thereby, bolstering the growth.

“Increasing R&D activities, new product launches by key manufacturers, and fast track drug approvals by regulatory bodies such as the U.S. Food and Drug Administration for acute and chronic migraine are expected to provide lucrative opportunities in the upcoming decade,” says the Fact.MR analyst.

Key Takeaways

  • Increasing cases of acute migraine are anticipated to spur the sales of intranasal migraine drugs
  • Hospital & retail pharmacies are anticipated to be the primary end-users for intranasal migraine drugs market
  • In terms of therapeutic class, opioids and antihistamines are expected to lead the segment throughout the forecast period
  • United States is anticipated to spearhead the Intranasal migraine drugs market growth in North America
  • UK will lead the second largest European Intranasal migraine drugs market through 2021

Prominent Drivers

  • Growing cases of chronic sinusitis are expected to accelerate the demand for Intranasal migraine drugs
  • Technological advancements in the healthcare industry for intranasal migraine drugs are expected to boost the market growth

Key Segments of Intranasal migraine drugs market Covered in the Report

Based on Intranasal migraine drugs Market, By Therapeutic class:

  • Corticosteroids
  • NSAID’S
  • Opioids
  • Antibiotics
  • Local Anaesthesia
  • Antihistamines 

Based on Intranasal migraine drugs Market, By Indication:

  • Common Migraine
  • Classic Migraine
  • Cluster Migraine
  • Others

Based on Intranasal migraine drugs Market, By Range:

  • Broad spectrum/ Chronic
  • Narrow spectrum/ Acute

Intranasal migraine drugs Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Third party manufacturing companies

Share Your Requirements & Get Customized Reports : https://www.factmr.com/report/intranasal-migraine-drugs-market  

Competitive Landscape

Key players listed by Fact.MR operating in global intranasal migraine drugs market includes Aegis Therapeutics LLC, Neuro Pharma, Rd. Reddy’s Laboratories, Novartis AG, Pfizer Inc., Lockhart LTD, Roche, Sanofi, Merck, Baxter International Inc., Becton, Dickinson & Company, GlaxoSmithKline PLC and Johnson & Johnson among others. Product launches and expansion of portfolio along with strategic mergers & acquisition remains the core strategies for the aforementioned players to gain a competitive edge in the industry.

For instance, on January 20th 2021, Impel Neuro Pharma received the approval from U.S. Food and Drug Administration (FDA) for the new drug application for INP104, for the acute treatment of migraine headaches with or without aura in adults to deliver a lower dose of dihydroergotamine mesylate to the upper nasal state. 

Also, on 2nd March 2021, Cipla received U.S FDA approval for nasal spray for treating migraine attacks/

Furthermore, in June 2020, Tonix Pharmaceuticals announced the acquisition of non-addictive migraine and pain treatment programs of Trigemina Inc. and will acquire the license of TNX-1900 intranasal oxytocin has the potential to treat migraine and craniofacial pain.

More Insights on the Intranasal Migraine Drugs Market

Fact.MR sheds an in-depth analysis on global intranasal migraine drugs market over the forecast period of 2021 and 2031. In order to understand the market perspective, trends and challenges, the market is segmented on the basis of therapeutic class (corticosteroids, NSAID’s, opioids, antibiotics, local anesthesia, and antihistamines), indication (common migraine, classic migraine, cluster migraine, and others), range (chronic and acute), distribution channel (hospital pharmacies, retail pharmacies, online pharmacies, and third party manufacturing companies), and regions (North America, Latin America, Europe, CIS & Russia, Asia Pacific excluding Japan, Japan and Middle East & Africa). 

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/long-term-disability-management-to-drive-bulk-of-medical-case-management-services-market-growth/

Explore Fact.MR’s Coverage on the Healthcare Domain

Bone Growth Stimulator Market: A recent study by Fact.MR on the bone growth stimulator market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth.

Bone Marrow Processing System Market: Fact.MR gives a detailed assessment of bone marrow processing system market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

Injectable Bone Graft Substitutes Market: Fact.MR delivers an in-depth analysis on global injectable bone graft substitutes market with the strategies and competitive landscape through 2021 and beyond. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com